WCM
NVS icon

Wallace Capital Management’s Novartis NVS Stock Holding History

Wallace Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-99,157
Closed -$9.05M – 66
2019
Q2 		$9.05M Sell
99,157
-12,470
-11% -$1.06M 1.19% 24
2019
Q1 		$9.62M Buy
111,627
+694
+0.6% +$55.7K 1.33% 23
2018
Q4 		$8.53M Sell
110,933
-150
-0.1% -$11.7K 1.24% 24
2018
Q3 		$8.58M Buy
111,083
+1,131
+1% +$83.6K 1.09% 28
2018
Q2 		$7.44M Buy
109,952
+3,393
+3% +$234K 0.99% 28
2018
Q1 		$7.72M Buy
106,559
+12,293
+13% +$936K 1.1% 27
2017
Q4 		$7.09M Buy
94,266
+799
+0.9% +$60.3K 1.08% 24
2017
Q3 		$7.19M Buy
93,467
+5,384
+6% +$407K 1.15% 24
2017
Q2 		$6.59M Buy
88,083
+2,592
+3% +$184K 1.05% 25
2017
Q1 		$5.69M Buy
85,491
+3,597
+4% +$240K 0.97% 26
2016
Q4 		$5.35M Sell
81,894
-140
-0.2% -$9.08K 0.97% 26
2016
Q3 		$5.8M Buy
82,034
+2,088
+3% +$152K 1.02% 25
2016
Q2 		$5.91M Buy
79,946
+5,231
+7% +$361K 0.98% 23
2016
Q1 		$4.85M Buy
74,715
+2,857
+4% +$194K 0.86% 27
2015
Q4 		$5.54M Buy
71,858
+1,311
+2% +$104K 1.05% 23
2015
Q3 		$5.81M Buy
70,547
+3,415
+5% +$304K 1.06% 24
2015
Q2 		$5.92M Buy
67,132
+723
+1% +$66.3K 1.03% 23
2015
Q1 		$5.87M Buy
66,409
+3,670
+6% +$326K 1.03% 22
2014
Q4 		$5.21M Buy
62,739
+3,649
+6% +$302K 1% 22
2014
Q3 		$4.98M Buy
59,090
+1,833
+3% +$148K 1.03% 26
2014
Q2 		$4.64M Buy
57,257
+2,610
+5% +$205K 0.98% 27
2014
Q1 		$4.16M Buy
54,647
+1,551
+3% +$113K 0.91% 28
2013
Q4 		$3.82M Buy
53,096
+1,759
+3% +$122K 0.88% 32
2013
Q3 		$3.53M Buy
51,337
+1,055
+2% +$69.8K 0.97% 31
2013
Q2 		$3.19M Buy
+50,282
New +$3.27M 0.96% 31

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Wallace Capital Management's NVS Position: Q3 2019 in Review

Wallace Capital Management sold out of Novartis (NVS) in Q3 2019, closing a stake of 99,157 shares — an estimated $9.05M sold.

Wallace Capital Management first reported a position in NVS in Q2 2013 and held it in 25 quarters. The position peaked at $9.62M in Q1 2019. 1,091 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

  • Wallace Capital Management reported no remaining Novartis position as of Q3 2019 after selling out during the quarter.
  • Wallace Capital Management sold 99,157 Novartis shares in Q3 2019, an estimated $9.05M.
  • Wallace Capital Management first reported a position in Novartis in Q2 2013 and held it in 25 quarters.
  • Wallace Capital Management's Novartis position peaked at $9.62M in Q1 2019.
  • 1,091 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Wallace Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.